Digital Dentistry’s Next Phase Is About Platforms, Not Products

Key Highlights

• Digital dentistry is becoming a platform market, with companies competing across imaging, AI, treatment planning and connected clinical workflows.
• Align Technology is launching a strategic review following discussions with activist investor Elliott Investment Management while expanding its board and increasing planned share repurchases.
• Envista Holdings and Dentsply Sirona report earnings next week, giving investors fresh insight into execution across digital orthodontics, diagnostics and connected dental technologies.
• The competitive landscape is shifting from individual products toward integrated digital ecosystems that support clinicians from diagnosis through treatment.

The global cosmetic dentistry market continues to expand as consumers increasingly seek aesthetic treatments and dental practices adopt digital technologies that improve diagnosis, treatment planning and patient engagement. But the industry’s next phase is no longer being defined by aligners, scanners or implants alone. It is becoming a competition to build the connected digital platforms that integrate every stage of modern dental care.

That shift came into focus as Align Technology (NASDAQ: ALGN) announced governance changes following discussions with activist investor Elliott Investment Management. The company plans to add three independent directors, launch a comprehensive strategic and operating review, and increase its planned 2026 share repurchases. At the same time, Align continues investing in its connected digital platform, bringing scanning, visualization, treatment planning, manufacturing and patient monitoring into a unified clinical workflow. Second-quarter results underscored both the opportunity and the challenge: while clear aligner demand remained resilient, the Imaging Systems business came under pressure from a shift toward lower-priced scanners and leasing models, reflecting the near-term tradeoffs of expanding recurring revenue and growing the installed base.

Envista Holdings (NYSE: NVST) enters earnings after a strong first quarter that included 9.5% core sales growth, expanding profitability and continued investment in AI-powered imaging, diagnostics and digital orthodontics. With second-quarter results scheduled for August 5, investors will be watching whether that momentum continues and whether the company’s investments in digital workflows continue translating into commercial execution.

Dentsply Sirona (NASDAQ: XRAY) is pursuing a different narrative. The company remains focused on its Return-to-Growth Action Plan while expanding distribution for its connected technology portfolio. Its recently announced expansion with Medline Sinclair extends access to digital dentistry technologies across Canada through one of the country’s largest dental distributors. When Dentsply reports second-quarter results on August 6, investors will likely be looking for evidence that commercial initiatives, AI-enabled diagnostics and workflow solutions are beginning to translate into stronger operating performance.

The broader investment story is becoming increasingly clear. Clear aligners, intraoral scanners, AI diagnostics, CAD/CAM software and practice management tools are evolving into integrated ecosystems rather than standalone products. The next phase of competition may not simply be about building the best digital platform, but about converting those platforms into sustainable revenue growth, expanding margins and recurring customer relationships. As Align, Envista and Dentsply Sirona report results and execute their respective strategies, investors will be watching not only who is innovating fastest, but who is demonstrating that digital dentistry can deliver durable financial performance.